Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates

Fortress Biotech (FBIO) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of$ 0.44. This compares to loss of $1.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -9.09%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.79 per share when it actually produced a loss of $0.26, delivering a surprise of 67.09%.Over the last four quarters, the c ...